<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04243525</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY19060285</org_study_id>
    <nct_id>NCT04243525</nct_id>
  </id_info>
  <brief_title>Inflammatory Bowel Disease (IBD) Research Registry</brief_title>
  <official_title>University of Pittsburgh Medical Center (UPMC) Center for Inflammatory Bowel Disease (IBD) Research Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients seen at the Center for Inflammatory Bowel Disease will be asked to provide their&#xD;
      written informed consent (authorization) to allow their identifiable medical record&#xD;
      information related to their Inflammatory Bowel Disease to be placed in Center's Research&#xD;
      Registry for the purpose of facilitating retrospective research studies directed at&#xD;
      Inflammatory Bowel Disease, and the identification and recruitment of potential, eligible&#xD;
      subjects for participation in future research studies involving Inflammatory Bowel Disease.&#xD;
&#xD;
      Information obtained from the Inflammatory Bowel Disease Registry will allow a better&#xD;
      classification of disease and factors that influence the natural course of disease; which may&#xD;
      lead to a better understanding of the pathogenesis of IBD and may permit the development of&#xD;
      better therapies and the potential for preventive therapies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2009</start_date>
  <completion_date type="Anticipated">May 2030</completion_date>
  <primary_completion_date type="Anticipated">May 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Number of patients with IBD</measure>
    <time_frame>20 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">4216</enrollment>
  <condition>Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients-subjects (age 18-100 years old) who are receiving or seeking medical care at&#xD;
        the Center for Inflammatory Bowel Diseases Clinic at UPMC&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All patients age 18 and above seeking medical care at the Center for Inflammatory Bowel&#xD;
        Diseases Clinic at UPMC&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        N/A&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>David Binion, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joann Fultz</last_name>
    <email>jdf23@pitt.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joann Fultz</last_name>
      <phone>412-648-7402</phone>
      <email>jdf23@pitt.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 24, 2020</study_first_submitted>
  <study_first_submitted_qc>January 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>David Binion, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

